2018 International Congress » Neuropharmacology

1:45pm-3:15pm

Abrogation of Rotenone Induced Behavior, Biochemical and Mitochondrial Deficits in Mice by Curcumin and Ginkgo Biloba: New Combinational Therapy Approach for Parkinson’s Disease

D. Khatri, M. Panchwadkar, P. Rane, V. Undale (Pune, India)

1:45pm-3:15pm

Artisanal formulations of Cannabis in Movement Disorders. The real-life perspective in a population from Buenos Aires, Argentina. Preliminary report

M. Cesarini, JL. Etcheverry, N. Gonzalez Rojas, G. Da Prat, V. Parisi, G. Rojas, G. Persi, E. Gatto (Buenos Aires, Argentina)

1:45pm-3:15pm

Chlorogenic acid exerts anti-neuroinflammatory effect by suppressing NF-κB pathway in Parkinsonian mice model

S. Singh, S. Rai, H. Birla, W. Zahra, S. Singh (Varanasi, India)

1:45pm-3:15pm

Clinical practice of levodopa in parkinsonism

AC. Chen (Taichung, Taiwan)

1:45pm-3:15pm

Could curcumin be the preventive key of parkinson’s disease?

W. Laabbar, A. Elgot, H. Gamrani (Marrakech, Morocco)

1:45pm-3:15pm

Delivery of AAV alpha synuclein to a mouse and rat provides a useful model for the assessment of anti-parkinsonian efficacy of chronic inhibition of LRRK2

R. Hodgson, T. Parkkari, T. Martinez, M. Fell, D. Bryce, T. Heikkinen, A. Nurmi, T. Bragge, M. Taavitsainen, T. Lanz, M. Baptista (Wilmington, MA, USA)

1:45pm-3:15pm

Differential glial and neuronal response in Lipopolysaccharide induced Parkinson’s disease model: Modulation with Apocyanin and Curcumin

N. Sharma, B. Nehru (Chandigarh, India)

1:45pm-3:15pm

Dopaminergics are alternative for the treatment of Bell`s paralysis in acute period

A. Azimov, R. Sadykov, G. Rakhimbaeva, F. Azimov (Tashkent, Uzbekistan)

1:45pm-3:15pm

Economics of Botulinum Toxin Therapy: Influence of the AbobotulinumtoxinA Package Size on the Costs of Botulinum Toxin Therapy

F. Adib Saberi, D. Dressler (Hamburg, Germany)

1:45pm-3:15pm

Ginsenoside Rb1 protects dopaminergic neurons through Foxm1-Nurr1 pathway in mice model of Parkinson’s disease

T. Zhou, X. Huang, L. Li, J. Yang, Z. Liang (Dalian, China)

1:45pm-3:15pm

Long Term Response to L-dopa in Parkinson Disease

H. Gupta, N. Wachter, K. Lyons, R. Pahwa (Kansas, KS, USA)

1:45pm-3:15pm

Lycopene ameliorates haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation

S. Jamwal, P. Kumar (Baddi, India)

1:45pm-3:15pm

Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration

K. Rode, D. Khatri, M. Panchawadkar, P. Rane (Pune, India)

1:45pm-3:15pm

Neuromodulatory properties of flavonoids from Persea americana Peel: Role in CNS redox homeostasis and neurobehavioral markers

S. Grace SR, PR, J. Chauhan, G. Chandran (Mys, India)

1:45pm-3:15pm

Neuroprotective Effects of A Combination of Curcumin and Mucuna Prurience in Rotenone Induced Mice Model of Parkinson’s Disease

M. Panchwadkar, P. Rane, D. Khatri, V. Undale (Pune, India)

1:45pm-3:15pm

Neuroprotective effects of coffee ingredients against rotenone-induced neurodegeneration in parkinsonian model

I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, Y. Kitamura, M. Asanuma (Okayama, Japan)

1:45pm-3:15pm

Role of metformin in diabetic aging female rat brain: a future therapy for neurodegenerative diseases

P. Kumar, N. Baquer (New Delhi, India)

1:45pm-3:15pm

Rotigotine protects dopaminergic neurons by targeting serotonin 1A receptors on astrocytes

M. Asanuma, I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, E. Nakayama, K. Shin, D. Yamamoto, Y. Kitamura (Okayama, Japan)

1:45pm-3:15pm

Safinamide inhibition of in vivo glutamate release in a rat model of Parkinson’s Disease

G. Padoani, S. Novello, C. Pisanò, C. Caccia, E. Melloni, S. Vailati, C. Keywood, M. Morari (Bresso (Milan), Italy)

1:45pm-3:15pm

The Small Molecule Alpha-Synuclein Misfolding Inhibitor, NPT200-11, Produces Multiple Benefits in an Animal Model of Parkinson’s Disease

D. Price, M. Koike, W. Wrasidlo, A. Khan, E. Rockenstein, E. Masliah, D. Bonhaus (San Diego, CA, USA)